ID   MTA3_HUMAN              Reviewed;         594 AA.
AC   Q9BTC8; Q9NSP2; Q9ULF4;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   28-FEB-2003, sequence version 2.
DT   28-JUN-2023, entry version 197.
DE   RecName: Full=Metastasis-associated protein MTA3;
GN   Name=MTA3; Synonyms=KIAA1266;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lymph, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 485-594.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   IDENTIFICATION IN NURD COMPLEX, INDUCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND FUNCTION.
RX   PubMed=12705869; DOI=10.1016/s0092-8674(03)00234-4;
RA   Fujita N., Jaye D.L., Kajita M., Geigerman C., Moreno C.S., Wade P.A.;
RT   "MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in
RT   breast cancer.";
RL   Cell 113:207-219(2003).
RN   [6]
RP   FUNCTION, INTERACTION WITH BCL6, AND IDENTIFICATION IN THE NURD COMPLEX.
RX   PubMed=15454082; DOI=10.1016/j.cell.2004.09.014;
RA   Fujita N., Jaye D.L., Geigerman C., Akyildiz A., Mooney M.R., Boss J.M.,
RA   Wade P.A.;
RT   "MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte
RT   differentiation.";
RL   Cell 119:75-86(2004).
RN   [7]
RP   FUNCTION, IDENTIFICATION IN THE NURD COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16428440; DOI=10.1128/mcb.26.3.843-851.2006;
RA   Le Guezennec X., Vermeulen M., Brinkman A.B., Hoeijmakers W.A., Cohen A.,
RA   Lasonder E., Stunnenberg H.G.;
RT   "MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical
RT   and functional properties.";
RL   Mol. Cell. Biol. 26:843-851(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-455 AND SER-519, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428 AND SER-519, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   INTERACTION WITH NACC2.
RX   PubMed=22926524; DOI=10.1038/onc.2012.386;
RA   Xuan C., Wang Q., Han X., Duan Y., Li L., Shi L., Wang Y., Shan L., Yao Z.,
RA   Shang Y.;
RT   "RBB, a novel transcription repressor, represses the transcription of HDM2
RT   oncogene.";
RL   Oncogene 32:3711-3721(2013).
RN   [11]
RP   FUNCTION, IDENTIFICATION IN THE NURD COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=28977666; DOI=10.1093/nar/gkx711;
RA   Hoffmeister H., Fuchs A., Erdel F., Pinz S., Groebner-Ferreira R.,
RA   Bruckmann A., Deutzmann R., Schwartz U., Maldonado R., Huber C.,
RA   Dendorfer A.S., Rippe K., Laengst G.;
RT   "CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping
RT   functionality.";
RL   Nucleic Acids Res. 45:10534-10554(2017).
RN   [12]
RP   IDENTIFICATION IN THE NURD COMPLEX, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=33283408; DOI=10.1111/febs.15650;
RA   Spruijt C.G., Graewe C., Kleinendorst S.C., Baltissen M.P.A., Vermeulen M.;
RT   "Cross-linking mass spectrometry reveals the structural topology of
RT   peripheral NuRD subunits relative to the core complex.";
RL   FEBS J. 288:3231-3245(2021).
CC   -!- FUNCTION: Acts as a component of the histone deacetylase NuRD complex
CC       which participates in the remodeling of chromatin (PubMed:16428440,
CC       PubMed:12705869, PubMed:28977666). Plays a role in maintenance of the
CC       normal epithelial architecture through the repression of SNAI1
CC       transcription in a histone deacetylase-dependent manner, and thus the
CC       regulation of E-cadherin levels (PubMed:12705869). Contributes to
CC       transcriptional repression by BCL6 (PubMed:15454082).
CC       {ECO:0000269|PubMed:12705869, ECO:0000269|PubMed:15454082,
CC       ECO:0000269|PubMed:16428440, ECO:0000269|PubMed:28977666}.
CC   -!- SUBUNIT: Component of the nucleosome remodeling and deacetylase (NuRD)
CC       repressor complex, composed of core proteins MTA1, MTA2, MTA3, RBBP4,
CC       RBBP7, HDAC1, HDAC2, MBD2, MBD3, and peripherally associated proteins
CC       CDK2AP1, CDK2AP2, GATAD2A, GATAD2B, CHD3, CHD4 and CHD5
CC       (PubMed:33283408, PubMed:12705869, PubMed:15454082, PubMed:28977666,
CC       PubMed:16428440). The exact stoichiometry of the NuRD complex is
CC       unknown, and some subunits such as MBD2 and MBD3, GATAD2A and GATAD2B,
CC       and CHD3, CHD4 and CHD5 define mutually exclusive NuRD complexes
CC       (PubMed:28977666, PubMed:16428440). Interacts with BCL6
CC       (PubMed:15454082). Interacts with NACC2 (PubMed:22926524). Interacts
CC       with PWWP2B (By similarity). {ECO:0000250|UniProtKB:Q924K8,
CC       ECO:0000269|PubMed:12705869, ECO:0000269|PubMed:15454082,
CC       ECO:0000269|PubMed:16428440, ECO:0000269|PubMed:22926524,
CC       ECO:0000269|PubMed:28977666, ECO:0000269|PubMed:33283408}.
CC   -!- INTERACTION:
CC       Q9BTC8; Q96KQ7: EHMT2; NbExp=18; IntAct=EBI-2461787, EBI-744366;
CC       Q9BTC8; P23771: GATA3; NbExp=18; IntAct=EBI-2461787, EBI-6664760;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00512,
CC       ECO:0000255|PROSITE-ProRule:PRU00624, ECO:0000269|PubMed:12705869,
CC       ECO:0000269|PubMed:28977666, ECO:0000269|PubMed:33283408}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q924K8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BTC8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BTC8-2; Sequence=VSP_001603, VSP_001604;
CC   -!- TISSUE SPECIFICITY: Expressed in germinal centers of lymphoid tissues.
CC       No expression in nonepithelial cells. {ECO:0000269|PubMed:12705869}.
CC   -!- INDUCTION: By estrogen. {ECO:0000269|PubMed:12705869}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86580.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/41445/mta3";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB033092; BAA86580.1; ALT_INIT; mRNA.
DR   EMBL; AK027304; BAB55028.1; -; mRNA.
DR   EMBL; BC004227; AAH04227.1; -; mRNA.
DR   EMBL; BC053631; AAH53631.1; -; mRNA.
DR   EMBL; AL161954; CAB82305.1; -; mRNA.
DR   CCDS; CCDS46267.1; -. [Q9BTC8-2]
DR   CCDS; CCDS82441.1; -. [Q9BTC8-1]
DR   PIR; T47180; T47180.
DR   RefSeq; NP_001269684.1; NM_001282755.1.
DR   RefSeq; NP_001269685.1; NM_001282756.1.
DR   RefSeq; NP_001317371.1; NM_001330442.1. [Q9BTC8-1]
DR   RefSeq; NP_065795.1; NM_020744.3. [Q9BTC8-2]
DR   AlphaFoldDB; Q9BTC8; -.
DR   SMR; Q9BTC8; -.
DR   BioGRID; 121568; 169.
DR   ComplexPortal; CPX-880; MBD2/NuRD nucleosome remodeling and deacetylase complex.
DR   ComplexPortal; CPX-922; MBD3/NuRD nucleosome remodeling and deacetylase complex.
DR   CORUM; Q9BTC8; -.
DR   DIP; DIP-47460N; -.
DR   IntAct; Q9BTC8; 61.
DR   MINT; Q9BTC8; -.
DR   STRING; 9606.ENSP00000383973; -.
DR   GlyGen; Q9BTC8; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9BTC8; -.
DR   MetOSite; Q9BTC8; -.
DR   PhosphoSitePlus; Q9BTC8; -.
DR   BioMuta; MTA3; -.
DR   DMDM; 29840798; -.
DR   EPD; Q9BTC8; -.
DR   jPOST; Q9BTC8; -.
DR   MassIVE; Q9BTC8; -.
DR   MaxQB; Q9BTC8; -.
DR   PaxDb; Q9BTC8; -.
DR   PeptideAtlas; Q9BTC8; -.
DR   ProteomicsDB; 78971; -. [Q9BTC8-1]
DR   ProteomicsDB; 78972; -. [Q9BTC8-2]
DR   Antibodypedia; 29760; 305 antibodies from 28 providers.
DR   DNASU; 57504; -.
DR   Ensembl; ENST00000405094.2; ENSP00000385823.1; ENSG00000057935.14. [Q9BTC8-1]
DR   Ensembl; ENST00000407270.7; ENSP00000385045.3; ENSG00000057935.14. [Q9BTC8-2]
DR   GeneID; 57504; -.
DR   KEGG; hsa:57504; -.
DR   MANE-Select; ENST00000405094.2; ENSP00000385823.1; NM_001330442.2; NP_001317371.1.
DR   UCSC; uc002rsq.5; human. [Q9BTC8-1]
DR   AGR; HGNC:23784; -.
DR   CTD; 57504; -.
DR   DisGeNET; 57504; -.
DR   GeneCards; MTA3; -.
DR   HGNC; HGNC:23784; MTA3.
DR   HPA; ENSG00000057935; Tissue enhanced (lymphoid).
DR   MIM; 609050; gene.
DR   neXtProt; NX_Q9BTC8; -.
DR   OpenTargets; ENSG00000057935; -.
DR   PharmGKB; PA134953540; -.
DR   VEuPathDB; HostDB:ENSG00000057935; -.
DR   eggNOG; KOG3554; Eukaryota.
DR   GeneTree; ENSGT01030000234573; -.
DR   InParanoid; Q9BTC8; -.
DR   OMA; HASQELD; -.
DR   OrthoDB; 12566at2759; -.
DR   PhylomeDB; Q9BTC8; -.
DR   TreeFam; TF106444; -.
DR   PathwayCommons; Q9BTC8; -.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-73762; RNA Polymerase I Transcription Initiation.
DR   Reactome; R-HSA-8943724; Regulation of PTEN gene transcription.
DR   Reactome; R-HSA-9679191; Potential therapeutics for SARS.
DR   SignaLink; Q9BTC8; -.
DR   SIGNOR; Q9BTC8; -.
DR   BioGRID-ORCS; 57504; 25 hits in 1181 CRISPR screens.
DR   ChiTaRS; MTA3; human.
DR   GeneWiki; MTA3; -.
DR   GenomeRNAi; 57504; -.
DR   Pharos; Q9BTC8; Tbio.
DR   PRO; PR:Q9BTC8; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9BTC8; protein.
DR   Bgee; ENSG00000057935; Expressed in right adrenal gland cortex and 159 other tissues.
DR   ExpressionAtlas; Q9BTC8; baseline and differential.
DR   Genevisible; Q9BTC8; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016581; C:NuRD complex; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:InterPro.
DR   GO; GO:0042826; F:histone deacetylase binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0120325; F:NuRD complex binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003713; F:transcription coactivator activity; IBA:GO_Central.
DR   GO; GO:0003714; F:transcription corepressor activity; IBA:GO_Central.
DR   GO; GO:0006338; P:chromatin remodeling; IDA:ComplexPortal.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:1990739; P:granulosa cell proliferation; IEA:Ensembl.
DR   GO; GO:0016575; P:histone deacetylation; IDA:ComplexPortal.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IMP:CACAO.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; NAS:ComplexPortal.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:1904197; P:positive regulation of granulosa cell proliferation; IEA:Ensembl.
DR   GO; GO:0042659; P:regulation of cell fate specification; NAS:ComplexPortal.
DR   GO; GO:2000736; P:regulation of stem cell differentiation; NAS:ComplexPortal.
DR   CDD; cd04709; BAH_MTA; 1.
DR   CDD; cd11661; SANT_MTA3_like; 1.
DR   CDD; cd00202; ZnF_GATA; 1.
DR   Gene3D; 2.30.30.490; -; 1.
DR   Gene3D; 4.10.1240.50; -; 1.
DR   Gene3D; 1.10.10.60; Homeodomain-like; 1.
DR   InterPro; IPR001025; BAH_dom.
DR   InterPro; IPR043151; BAH_sf.
DR   InterPro; IPR000949; ELM2_dom.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR040138; MIER/MTA.
DR   InterPro; IPR035170; MTA1_R1.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR017884; SANT_dom.
DR   InterPro; IPR000679; Znf_GATA.
DR   PANTHER; PTHR10865; METASTASIS-ASSOCIATED PROTEIN AND MESODERM INDUCTION EARLY RESPONSE PROTEIN; 1.
DR   PANTHER; PTHR10865:SF6; METASTASIS-ASSOCIATED PROTEIN MTA3; 1.
DR   Pfam; PF01426; BAH; 1.
DR   Pfam; PF01448; ELM2; 1.
DR   Pfam; PF00320; GATA; 1.
DR   Pfam; PF17226; MTA_R1; 1.
DR   Pfam; PF00249; Myb_DNA-binding; 1.
DR   SMART; SM00439; BAH; 1.
DR   SMART; SM01189; ELM2; 1.
DR   SMART; SM00717; SANT; 1.
DR   SMART; SM00401; ZnF_GATA; 1.
DR   SUPFAM; SSF46689; Homeodomain-like; 1.
DR   PROSITE; PS51038; BAH; 1.
DR   PROSITE; PS51156; ELM2; 1.
DR   PROSITE; PS51293; SANT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; DNA-binding; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Zinc; Zinc-finger.
FT   CHAIN           1..594
FT                   /note="Metastasis-associated protein MTA3"
FT                   /id="PRO_0000083498"
FT   DOMAIN          1..147
FT                   /note="BAH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00370"
FT   DOMAIN          148..259
FT                   /note="ELM2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00512"
FT   DOMAIN          266..318
FT                   /note="SANT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00624"
FT   ZN_FING         379..406
FT                   /note="GATA-type; atypical"
FT   MOD_RES         428
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         430
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q924K8"
FT   MOD_RES         455
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         519
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         509..515
FT                   /note="YADRHAE -> CKMLLNS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_001603"
FT   VAR_SEQ         516..594
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_001604"
FT   CONFLICT        1..9
FT                   /note="MAANMYRVG -> ATGGFPRDR (in Ref. 1; BAA86580)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        343
FT                   /note="Missing (in Ref. 1; BAA86580)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   594 AA;  67504 MW;  E773603F65A16DF1 CRC64;
     MAANMYRVGD YVYFENSSSN PYLIRRIEEL NKTASGNVEA KVVCFYRRRD ISNTLIMLAD
     KHAKEIEEES ETTVEADLTD KQKHQLKHRE LFLSRQYESL PATHIRGKCS VALLNETESV
     LSYLDKEDTF FYSLVYDPSL KTLLADKGEI RVGPRYQADI PEMLLEGESD EREQSKLEVK
     VWDPNSPLTD RQIDQFLVVA RAVGTFARAL DCSSSVRQPS LHMSAAAASR DITLFHAMDT
     LYRHSYDLSS AISVLVPLGG PVLCRDEMEE WSASEASLFE EALEKYGKDF NDIRQDFLPW
     KSLTSIIEYY YMWKTTDRYV QQKRLKAAEA ESKLKQVYIP TYSKPNPNQI STSNGKPGAV
     NGAVGTTFQP QNPLLGRACE SCYATQSHQW YSWGPPNMQC RLCAICWLYW KKYGGLKMPT
     QSEEEKLSPS PTTEDPRVRS HVSRQAMQGM PVRNTGSPKS AVKTRQAFFL HTTYFTKFAR
     QVCKNTLRLR QAARRPFVAI NYAAIRAEYA DRHAELSGSP LKSKSTRKPL ACIIGYLEIH
     PAKKPNVIRS TPSLQTPTTK RMLTTPNHTS LSILGKRNYS HHNGLDELTC CVSD
//
